×
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
NYSE:BHVN

Biohaven Pharmaceutical SEC Filings & 10K Form

$145.31
-0.40 (-0.27%)
(As of 07/1/2022 12:00 AM ET)
Add
Compare
Today's Range
$145.10
$145.92
50-Day Range
$83.14
$145.99
52-Week Range
$79.01
$151.51
Volume
880,622 shs
Average Volume
1.21 million shs
Market Capitalization
$10.25 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$155.11

Recent Biohaven Pharmaceutical SEC Filings

DateFilerForm TypeView
07/01/2022
4:20 PM
Biohaven Pharmaceutical (Filer)
Form PREM14A
06/28/2022
4:29 PM
Biohaven Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2022
1:57 PM
Biohaven Pharmaceutical (Subject)
Capital World Investors (Filed by)
Form SC 13G/A
06/10/2022
7:41 AM
Biohaven Pharmaceutical (Subject)
Capital International Investors (Filed by)
Form SC 13G/A
05/16/2022
5:24 AM
Biohaven Pharmaceutical (Filer)
Form DEFA14A
05/12/2022
7:58 PM
Biohaven Pharmaceutical (Issuer)
Clark George C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2022
7:57 PM
Antonijevic Irina (Reporting)
Biohaven Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2022
8:26 PM
Antonijevic Irina (Reporting)
Biohaven Pharmaceutical (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/11/2022
3:17 PM
Biohaven Pharmaceutical (Filer)
Form DEFA14A
05/10/2022
8:42 PM
Biohaven Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2022
4:29 PM
Biohaven Pharmaceutical (Filer)
Form DEFA14A
05/10/2022
4:29 PM
Biohaven Pharmaceutical (Filer)
Form DEFA14A
05/10/2022
4:28 PM
Biohaven Pharmaceutical (Filer)
Form DEFA14A
05/10/2022
4:28 PM
Biohaven Pharmaceutical (Filer)
Form DEFA14A
05/10/2022
4:27 PM
Biohaven Pharmaceutical (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/10/2022
10:56 AM
Biohaven Pharmaceutical (Subject)
Capital World Investors (Filed by)
Form SC 13G/A
05/10/2022
6:43 AM
Biohaven Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2022
6:16 AM
Biohaven Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2022
8:04 PM
Biohaven Pharmaceutical (Issuer)
Mehta Kishan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2022
8:03 PM
Biohaven Pharmaceutical (Issuer)
GREGORY JULIA P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2022
8:02 PM
Biohaven Pharmaceutical (Issuer)
CHILDS JOHN W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2022
8:00 PM
Biohaven Pharmaceutical (Issuer)
HUGIN ROBERT J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2022
7:59 PM
Bailey Gregory (Reporting)
Biohaven Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2022
7:58 PM
Biohaven Pharmaceutical (Issuer)
Heffernan Michael Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2022
4:22 PM
Biohaven Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2022
1:27 PM
Biohaven Pharmaceutical (Filer)
Form DEFA14A
04/15/2022
1:23 PM
Biohaven Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2021
7:44 PM
Biohaven Pharmaceutical (Issuer)
Clark George C. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/09/2021
3:34 PM
Biohaven Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/07/2021
1:05 PM
Biohaven Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/29/2021
7:51 AM
Biohaven Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/22/2021
3:02 PM
Biohaven Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2021
8:51 PM
Biohaven Pharmaceutical (Issuer)
Mehta Kishan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2021
8:50 PM
Biohaven Pharmaceutical (Issuer)
Mehta Kishan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/01/2021
5:55 AM
Biohaven Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2021
8:54 PM
Biohaven Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2021
4:25 PM
Biohaven Pharmaceutical (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/10/2021
3:45 PM
Biohaven Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/13/2021
3:33 PM
Biohaven Pharmaceutical (Filer)
Form DEFA14A
04/08/2021
3:43 PM
Biohaven Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/17/2021
4:13 PM
Biohaven Pharmaceutical (Issuer)
CHILDS JOHN W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2021
3:44 PM
Biohaven Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/17/2021
5:01 AM
Biohaven Pharmaceutical (Filer)
Form 424B5
03/15/2021
4:26 PM
Biohaven Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/15/2021
4:24 PM
Biohaven Pharmaceutical (Filer)
Form 424B7
03/15/2021
3:35 PM
Biohaven Pharmaceutical (Filer)
Form 424B5
03/05/2021
7:54 PM
Biohaven Pharmaceutical (Issuer)
Conway Charles (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
03/05/2021
4:01 PM
Biohaven Pharmaceutical (Filer)
Form S-3ASR
03/03/2021
8:22 PM
Biohaven Pharmaceutical (Issuer)
CHILDS JOHN W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
4:29 PM
Biohaven Pharmaceutical (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/01/2021
4:09 PM
Biohaven Pharmaceutical (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/16/2021
1:04 PM
Biohaven Pharmaceutical (Subject)
Capital World Investors (Filed by)
Form SC 13G
02/12/2021
8:51 PM
Biohaven Pharmaceutical (Issuer)
Coric Vlad (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/12/2021
8:51 PM
Biohaven Pharmaceutical (Issuer)
GREGORY JULIA P (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/12/2021
8:51 PM
Biohaven Pharmaceutical (Issuer)
CHILDS JOHN W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2021
6:04 AM
Biohaven Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2021
7:49 PM
Biohaven Pharmaceutical (Issuer)
Tilton John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2021
7:49 PM
Biohaven Pharmaceutical (Issuer)
JONES WILLIAM A JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2021
7:49 PM
Biohaven Pharmaceutical (Issuer)
Stock Elyse (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2021
7:48 PM
Biohaven Pharmaceutical (Issuer)
Gentile Kimberly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2021
7:48 PM
Biohaven Pharmaceutical (Issuer)
Engelhart James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2021
7:48 PM
Biohaven Pharmaceutical (Issuer)
Conway Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2021
7:48 PM
Biohaven Pharmaceutical (Issuer)
Coric Vlad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2020
3:12 PM
Biohaven Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2020
3:02 PM
Biohaven Pharmaceutical (Filer)
Form 424B5
11/27/2020
8:48 PM
Biohaven Pharmaceutical (Issuer)
Tilton John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2020
8:48 PM
Biohaven Pharmaceutical (Issuer)
Stock Elyse (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2020
8:48 PM
Biohaven Pharmaceutical (Issuer)
JONES WILLIAM A JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2020
8:48 PM
Biohaven Pharmaceutical (Issuer)
Gentile Kimberly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2020
8:47 PM
Biohaven Pharmaceutical (Issuer)
Engelhart James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2020
8:47 PM
Biohaven Pharmaceutical (Issuer)
Coric Vlad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2020
8:47 PM
Biohaven Pharmaceutical (Issuer)
Conway Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/23/2020
7:40 PM
Biohaven Pharmaceutical (Issuer)
CHILDS JOHN W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2020
4:24 PM
Biohaven Pharmaceutical (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/09/2020
3:05 PM
Biohaven Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2020
7:31 PM
Biohaven Pharmaceutical (Issuer)
JONES WILLIAM A JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2020
8:25 PM
Bailey Gregory (Reporting)
Biohaven Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/21/2020
8:24 PM
Bailey Gregory (Reporting)
Biohaven Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/14/2020
8:31 PM
Bailey Gregory (Reporting)
Biohaven Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2020
5:42 PM
Biohaven Pharmaceutical (Issuer)
Gentile Kimberly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/22/2020
8:51 PM
Biohaven Pharmaceutical (Issuer)
CHILDS JOHN W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2020
7:49 PM
Biohaven Pharmaceutical (Issuer)
CHILDS JOHN W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2020
5:25 PM
Biohaven Pharmaceutical (Issuer)
CHILDS JOHN W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2020
6:47 AM
Biohaven Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2020
8:16 PM
Bailey Gregory (Reporting)
Biohaven Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2020
8:15 PM
Berman Robert (Reporting)
Biohaven Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2020
8:49 PM
Bailey Gregory (Reporting)
Biohaven Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2020
8:49 PM
Berman Robert (Reporting)
Biohaven Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2020
8:58 PM
Bailey Gregory (Reporting)
Biohaven Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2020
8:57 PM
Berman Robert (Reporting)
Biohaven Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2020
8:51 PM
Biohaven Pharmaceutical (Issuer)
Gentile Kimberly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2020
8:55 PM
Biohaven Pharmaceutical (Issuer)
Gentile Kimberly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2020
8:55 PM
Biohaven Pharmaceutical (Issuer)
Doogan Declan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
8:51 PM
Biohaven Pharmaceutical (Issuer)
HUGIN ROBERT J (Reporting)
Form 3/A
06/12/2020
8:51 PM
Biohaven Pharmaceutical (Issuer)
Stock Elyse (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
7:09 PM
Biohaven Pharmaceutical (Issuer)
Doogan Declan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
4:58 PM
Biohaven Pharmaceutical (Issuer)
HUGIN ROBERT J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
4:57 PM
Biohaven Pharmaceutical (Issuer)
HUGIN ROBERT J (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/12/2020
4:19 PM
Biohaven Pharmaceutical (Issuer)
Tilton John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
4:19 PM
Biohaven Pharmaceutical (Issuer)
Engelhart James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page (NYSE:BHVN) was last updated on 7/2/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.